Expression and immunogenicity in rats of recombinant adenovirus 5 DNA plasmids and vaccinia virus containing the HTLV-I env gene

International Journal of Cancer

Volumn 71, Issue 2, 1997, Pages 300-307

  Kazanji, Mirdad ^a   Bomford, Robert ^a   Bessereau, Jean Louis ^a   Schulz, Thomas ^b   De Thé, Guy ^a  

^a Institut Pasteur   (France)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA; VIRUS VACCINE;

ADENOVIRUS 5; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; HELA CELL; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNIZATION; IMMUNOGENICITY; NONHUMAN; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; VACCINIA VIRUS; VIRUS EXPRESSION; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; BLOTTING, WESTERN; CYTOTOXICITY, IMMUNOLOGIC; DNA PRIMERS; DNA, VIRAL; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION REGULATION, VIRAL; GENES, ENV; HELA CELLS; HTLV-I ANTIBODIES; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; PLASMIDS; RATS; RATS, INBRED F344; RATS, INBRED WKY; T-LYMPHOCYTES, CYTOTOXIC; VACCINIA VIRUS; VIRAL ENVELOPE PROTEINS;

EID: 0030993643     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970410)71:2<300::AID-IJC27>3.0.CO;2-J     Document Type: Article

References (21)

1. AMI, Y., KUSHIDA, S., MATSUMURA, M., YOSHIDA, Y., KAMEYAMA, T., SUGIYAMA, Y., YAGAMI, K., UCHIDA, M., UCHIDA, K., KOISO, K. and MIWA, M., Vertical transmission of HTLV-1 in HTLV-1 carrier rat. Jap. J. Res., 83, 1241-1243 (1992).
2. BABA, E., NAKAMURA, M., OHKUMA, K., KIRA, J., TANAKA, Y., NAKANO, S. and NIHO, Y., A peptide-based human T-cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies. J. Immunol., 154, 399-412 (1995).
3. BESSEREAU, J.L., STRATFORD-PERRICAUDET, L., PIETTE, J., LE POUPON, C. and CHANGEUX, J.P., In vivo and in vitro analysis of electrical-activity-dependent expression of muscle acetylcholine receptor genes using adenovirus. Proc. nat. Acad. Sci. (Wash.), 91, 1304-1308 (1994).
4. BOMFORD, R., KAZANJI, M. and DE THÉ, G., Vaccine against human T-cell leukemia-lymphoma virus type I: progress and prospects. AIDS Res. hum. Retroviruses, 12, 403-405 (1996).
5. DE THÉ, G. and GESSAIN, A., Proceedings of the VIIth International Conference on Human Retrovirology. J. AIDS hum. Retrovirol., 13(suppl. 1), (1996).
6. EDOUARD, E., LEGRAND, E., ASTIER-GIN, T., DALIBART, R., GEOFFRE, S., DALBON, P., GUILLEMAIN, B. and LONDOS-GAGLIARDI, D., Characterization of monoclonal antibodies directed against the gp46 of human T-cell leukemia virus type I. Leukemia Supp., 8, s60-s64 (1994).
7. FRANCHINI, G., TARTAGLIA, J., MARKHAM, P., BENSON, J., FULLEN, J., WILLS, M., ARP, J., DEKABAN, G., PAOLETTI, E. and GALLO, R.C., Highly attenuated HTLV type-Ienv poxvirus vaccines induce protection against a cell-associated HTLV type-I challenge in rabbits. AIDS Res. hum. Retroviruses, 11, 307-313 (1995).
8. GABARRE, J., GESSAIN, A., RAPHAEL, M., MERLE-BERAL, H., DUBOURG, O., FOURCADE, C., GANDJBAKHNH, I., JAULT, F., DELCOURT, A. and BINET, J.L., Adult T-cell leukemia/lymphoma revealed by a surgically cured cardiac valve lymphomatous involvement in an Iranian woman: clinical, immunopathological and viromolecular studies. Leukemia, 7, 1904-1909 (1993).
9. GRAHAM, F.L., SMILEY, J., RUSELL, W.C. and NAIRN, R., Characteristics of human cell line transformed by DNA from human adenovirus type 5. J. gen. Virol., 36, 59-72 (1977).
10. HAKODA, E., MACHIDA, H., TANAKA, Y., MORISHITA, N., SAWADA, T., SHIDA, H., HOSHINO, H. and MIYOSHI, I., Vaccination of rabbits with recombinant vaccinia virus carrying the envelope gene of human T-cell lymphotropic virus type I. Int. J. Cancer, 60, 567-570 (1995).
11. IBRAHIM, F., FIETTE, L., GESSAIN, A., BUISSON, N., DE THÉ, G. and BOMFORD, R., Infection of rats with human T-cell leukemia virus type I: susceptibility of inbred strains, antibody response and provirus location. Int. J. Cancer, 58, 446-451 (1994).
12. ISHIGURO, N., ABE, M., SETO, K., SAKURAI, H., IKEDA, H., WAKISAKA, A., TOGASHI, T., TATENO, M. and YOSHIKI, T., A rat model of human T lymphocyte virus type-I (HTLV-I) infection. I. Humoral antibody response, provirus integration, and HTLV-I-associated myelopathy/tropical spastic paraparesis-like myelopathy in seronegative HTLV-I carrier rats. J. exp. Med., 176, 981-989 (1992).
13. ITOH, M., INOUE, J., TOYOSHIMA, H., AKIZAWA, T., HIGASHI, M. and YOSHIDA, M., HTLV-I rex and HIV-I rev act through similar mechanisms to relieve suppression of unspliced RNA expression. Oncogene, 4, 1275-1279 (1989).
14. LUBECK, M., DAVIS, A.R., CHENGALVA, M., NATUK, R.J., MORIN, J.E., MOLNAR-KIMBER, K., MASSON, B.B., BHAT, B.M., MIZUTANI, S., HUNG, P.P. and PURCELL, R.H., Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis vaccine based on live recombinant adenovirus. Proc. nat. Acad. Sci. (Wash.), 86, 6763-6767 (1989).
15. MAHIEUX, R., DE THÉ, G. and GESSAIN, A., The tax mutation at nucleotide 7959 of human T-cell leukemia virus type I (HTLV-I) is not associated with tropical spastic paraparesis/HTLV-I associated myelopathy but is linked to the cosmopolitan molecular genotype. J. Virol., 69, 5925-5927 (1995).
16. MIYAKOSHI, H., KOIDE, H. and AOKI, T., In vitro antibody-dependent cellular cytotoxicity against human T-cell leukemia/lymphoma virus (HTLV)-producing cells. Int. J. Cancer, 33, 287-291 (1984).
17. NAKAMURA, H., HAYAMI, M., OHTA, Y., ISHIKAWA, K., TSUJIMOTO, H., KIYOKAWA, T., YOSHIDA, M., SASAGAWA, A. and HONJO, S., Protection of cynomolgus monkeys against infection by human T-cell leukemia virus type-I by immunization with viral env gene products produced in Escherichia coli. Int. J. Cancer, 40, 403-407 (1987).
18. NOGUCHI, Y., TATENO, M., KONDO, N., YOSHIKI, T., SHIDA, H., NAKAYAMA, E. and SHIKU, H., Rat cytotoxic T lymphocytes against human T-lymphotropic virus typc-I infected cells recognize gag gene and env gene encoded antigens. J. Immunol., 143, 3737-3742 (1989).
19. RAGOT, T., FINERY, S., WATKINS, P.E., PERRICAUDET, M. and MORGAN, A.J., Replication-defective recombinant adenovirus expressing the Epstein-Barr virus (EBV) envelope glycoproteins gp340/220 induces protective immunity against EBV-induced lymphomas in the cotton-top tamarin. J. gen. Virol., 74, 501-507 (1993).
20. SHIDA, H. and 16 OTHERS. Effect of the recombinant vaccinia viruses that express HTLV-I envelope gene on HTLV-I infection. EMBO J., 6, 3379-3384 (1987).
21. TOP, F.H., Control of adenovirus acute respiratory disease in US Army trainees. Yale J. Med., 48, 185-195 (1975).